Navigation Links
BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Date:7/28/2009

BIRMINGHAM, Ala., July 28 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that its second quarter 2009 financial results will be released on Thursday, July 30, 2009. BioCryst will host a conference call and Web cast at 11:00 a.m. Eastern Time to discuss the financial results and provide an update on the Company's programs. The call will be led by Jon P. Stonehouse, President and Chief Executive Officer, Stuart Grant, Chief Financial Officer and Dr. William P. Sheridan, Chief Medical Officer.

The Web cast can be accessed by logging onto http://www.biocryst.com. Please connect to the Web site at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed. To participate in the conference call, please dial 1-877-627-6566 (United States) or 1-719-325-4922 (International). No passcode is needed for the call. The audio portion of the Web cast will be archived and available for replay for at least 14 days.

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in oncology, infectious and autoimmune diseases. BioCryst has two product candidates in pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to expand its portfolio of next-generation therapeutic candidates with the potential to address the unmet medical needs of patients and physicians. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
2. BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference
3. BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition
4. BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
5. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
6. BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
7. BioCryst to Present at the JMP Healthcare Focus Conference
8. BioCryst to Present at UBS 2008 Global Life Sciences Conference
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
11. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... July 2, 2015 College of DuPage students ... are gaining invaluable real-world experiences while serving biophysics internships ... The students will be working as a ... group at IIT. The internship came about from ... , Physics; Dr. Kathy Finan , Biology; and ...
(Date:7/2/2015)... TN (PRWEB) , ... July 02, 2015 , ... ... the development and manufacturing of surgical instruments in Orthopedics, announced today the acquisition ... contract-manufacturing and the world's largest provider of surgical instruments to the Spine Industry. ...
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) ... market segments, including the molecular diagnostics industry. BCC Research reveals in its new report ... tests, lower test costs, and a growing need for better diagnostics as part of ...
(Date:7/1/2015)... , July 1, 2015 Isagenix International, a ... earned three Gold, three Silver, and three Bronze Stevie® ... held in Chicago this month.The ... premier business awards program in the U.S. ... company,s strength in developing leaders, cultivating talent, creating a ...
Breaking Biology Technology:COD Students Participate in Prestigious Summer Internships 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3
... Ariadne, a leader in bioinformatics software and knowledge ... site license for the use of Pathway Studio® ... applying innovative technologies, Georgetown Lombardi Comprehensive Cancer Center ... their efforts to unravel cancer disease biology, disease ...
... Qteros, Inc., the developer of a unique ... for the lowest-cost production of cellulosic ethanol, today announced ... and Europe for members of its senior management team. ... Development and Engineering, will present on a panel entitled, ...
... new combination of nanoparticles and graphene results in a more ... today online at the Journal of the American Chemical Society. ... active as well. The researchers are confident the results will ... important area of energy technology, but cost and durability are ...
Cached Biology Technology:Georgetown Lombardi Comprehensive Cancer Center Taps Ariadne for G-DOC Pathway Data and Tools 2Georgetown Lombardi Comprehensive Cancer Center Taps Ariadne for G-DOC Pathway Data and Tools 3Qteros Management to Present at Notable Alternative Energy Conferences in February 2A paperweight for platinum 2A paperweight for platinum 3
(Date:6/30/2015)... To bolster its efforts and commitment to fighting ... the addition of two new team members. ... David Raviv will act as head of strategic ... to providing the most secure solutions for the enterprise market. ... 7 Technologies, a provider of security and management products, which ...
(Date:6/26/2015)... -- ATL Technology, LLC, a top provider of electromechanical contract ... solutions, headquartered in Springville, Utah , has ... corporation with locations in Santa Clara, ... ). This acquisition will incorporate MedConx,s manufacturing ... Technology,s existing facility in Costa Rica , ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
... Harrison, Director of the School of Policy Studies at ... this week at an international think tank on "The ... Nunavut. The Canada-UK Colloquium is organized annually ... in Britain, to generate discussion and research about issues ...
... headed by Llus Ribas de Pouplana, ICREA professor at the ... as "Paper of the week" in the December issue of ... available online. The article describes the discovery of a new ... that is crucial for mitochondria. The removal of SLIMP in ...
... Energy Biosciences Institute (EBI) in Berkeley projects that ... much more long-term research, development and demonstration. In ... serve to advance the nascent industry. "Even ... cultivation to harvesting to processing), algae oil production ...
Cached Biology News:Scientists at IRB Barcelona discover a new protein critical for mitochondria 2Algae for biofuels: Moving from promise to reality, but how fast? 2Algae for biofuels: Moving from promise to reality, but how fast? 3Algae for biofuels: Moving from promise to reality, but how fast? 4
... score SNPs, Polymorphic uses proven, validated Sanger ... DNA analysis. We use high throughput capillary ... confirmed by sequencing in both directions. The ... context information, further confirming the location of ...
... Model 96 and PowerPac basic power supply are ... acids in agarose gels. This Model 96 cell ... cm UV-transparent gel tray with fluorescent ruler, and ... 100-120 and 220-240 V, provides output of 10-300 ...
... and PowerPac basic power supply are used for ... agarose gels. The mini format cell includes a ... leveling bubble. The PowerPac basic power supply, 100-120 ... 4-400 mA, and 75 W. Power cord and ...
... mini ReadySub-Cell GT cell and PowerPac basic power ... of nucleic acids in agarose gels. The wide ... with cables and electrodes, and leveling bubble. The ... provides output of 10-300 V, 4-400 mA, and ...
Biology Products: